Barclays’s Avanos Medical AVNS Stock Holding History

Barclays’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-35,000	Closed	-$2M	–	7106
2018 Q2	$2M	Buy	+35,000	New	+$1.85M	﹤0.01%	2585
2017 Q1	–	Sell	-96	Closed	-$4K	–	6741
2016 Q4	$4K	Hold	96	–	–	﹤0.01%	6168
2016 Q3	$3K	Hold	96	–	–	﹤0.01%	6119
2016 Q2	$3K	Hold	96	–	–	﹤0.01%	5845
2016 Q1	$3K	Sell	96 -732	-88%	-$19.5K	﹤0.01%	5778
2015 Q4	$27K	Hold	828	–	–	﹤0.01%	5090
2015 Q3	$23K	Hold	828	–	–	﹤0.01%	5388
2015 Q2	$33K	Sell	828 -240	-22%	-$10.8K	﹤0.01%	5394
2015 Q1	$52K	Sell	1,068 -3,528	-77%	-$163K	﹤0.01%	5249
2014 Q4	$207K	Buy	+4,596	New	+$181K	﹤0.01%	4606

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Barclays's AVNS Position: Q1 2026 in Review

Barclays reduced its Avanos Medical (AVNS) stake by 80% in Q1 2026, selling an estimated $757K and leaving 13,786 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #3711.

Barclays first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.7M in Q3 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Barclays held 13,786 shares of Avanos Medical worth $193K as of Q1 2026.
Barclays sold 56,152 Avanos Medical shares in Q1 2026, an estimated $757K.
Avanos Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3711 holding.
Barclays first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
Barclays's Avanos Medical position peaked at $5.7M in Q3 2018.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.